Rate My Professor Simon Timpka

The primary focus of Timpka's research is to improve the health of women and their children across the life-span through high-quality epidemiological studies. He investigates the relevance of pregnancy complications, particularly preeclampsia, for the development and subsequent treatment of coronary heart disease in women. The PACE unit, under his leadership, employs cross-disciplinary expertise in epidemiology, clinical women’s health, statistics, and clinical research methodology, bridging obstetrics and gynecology, cardiology, endocrinology, and life-course epidemiology. Key publications include 'Incident Cardiovascular Disease in Women With Type 1 or Type 2 Diabetes Following a Hypertensive Disorder of Pregnancy' (Hypertension, 2024), 'Association Between History of Adverse Pregnancy Outcomes and Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography' (JAMA, 2023), 'Coronary Artery Restenosis in Women by History of Preeclampsia' (Journal of the American Heart Association, 2022), 'The value of pregnancy complication history for 10-year cardiovascular disease risk prediction in middle-aged women' (European Journal of Epidemiology, 2018), and 'Lifestyle in progression from hypertensive disorders of pregnancy to chronic hypertension in Nurses' Health Study II: Observational cohort study' (BMJ, 2017). Timpka has produced 35 research outputs, including 33 articles and one letter, contributing to advancements in perinatal and cardiovascular health research. The PACE unit is supported by grants from the Swedish Research Council, the Swedish Heart-Lung Foundation, the Swedish Society of Medicine, and the Jeansson Foundations.